Table 1 Pre-operative patient characteristics
Patient | Sex | Etiology of infection | Age (yrs) | Habits and co-morbidities | Isolated microorganism |
|---|---|---|---|---|---|
MZ | M | Post-osteosynthesis | 42 | Smoking - Drug abuse | MSSA |
GS | M | Post-osteosynthesis | 56 | Smoking - Alcohol abuse | MRSA |
MC | F | Post-osteosynthesis | 30 | / | MRSA |
FS | F | Hematogenous | 61 | Diabetes | MSSA |
MB | F | Intra-articular injection | 63 | / | MSSA |
AP | M | Post-osteosynthesis | 46 | Smoking - Diabetes | Enterococcus |
MO | M | Post-osteosynthesis | 66 | Smoking | MRSA |
FF | F | Hematogenous (bilateral) | 52 | Radiotherapy - Lymphedema | MSSA |
GB | F | Post-osteosynthesis | 75 | Diabetes | Neg |
PI | F | Hematogenous | 61 | Smoking - Diabets | MSSA |
GF | M | Hematogenous | 32 | Smoking - Diabetes | CoNS |
CC | M | Hematogenous | 64 | Vasculopathy | Neg |
MR | M | Post-osteosynthesis | 47 | / | Neg |
TS | M | Post-osteosynthesis | 61 | / | MRSA |
LL | F | Post-osteosynthesis | 39 | Diabetes | Pseudomonas aeruginosa |
GR | F | Hematogenous | 66 | Rheumatoid arthritis | MSSA |
DA | M | Post-osteosynthesis | 66 | / | CoNS |
GL | F | Hematogenous | 55 | Lymphoma | Neg |
PQ | F | Post-osteosynthesis | 77 | Diabetes | CoNS |